Compared to serum prostate-specific antigen (PSA), which is a gold standard for monitoring prostate cancer but has low sensitivity and specificity in terms of diagnosing prostate cancer, ExoDx Prostate showed better performance in detecting high-grade prostate carcinoma. Here, KLK3 is linked to prostate carcinoma.